The Next US FDA Center Of Excellence? Pazdur Thinks It Should Be (Surprise!) Biostatistics
Executive Summary
A central biostatistics team would embrace an academic focus that could elevate the specialty within FDA. It’s a question, Pazdur says, for the next commissioner.